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INTRODUCTION {#ccd26372-sec-0005}
============

The importance of time to reperfusion in primary percutaneous coronary intervention (PCI) for ST‐elevation myocardial infarction (STEMI) has been clearly demonstrated with a powerful relationship between delays in door‐to‐balloon time and increased mortality [1](#ccd26372-bib-0001){ref-type="ref"}. Intense focus on door‐to‐balloon time by cardiologists and hospitals has led to a substantial increase in the proportion of STEMI patients with door‐to‐balloon times ≤90 min from 44.2% in 2005 to 91.4% in 2010 in a Medicare public reporting database [2](#ccd26372-bib-0002){ref-type="ref"}. The Medicare public reporting database, however, only includes a small minority of patients undergoing emergency percutaneous intervention (Fig. [1](#ccd26372-fig-0001){ref-type="fig"}). In one series, the public reporting measure only included 13% of STEMI patients as STEMI patients with an initial ECG without ST elevation and in‐hospital and transfer STEMI patients are all excluded [3](#ccd26372-bib-0003){ref-type="ref"}. In addition, public reporting of door‐to‐balloon time has been associated with an increase in patients excluded due to "acceptable" nonsystem delays from 3.7% in 2005 to 8.1% in 2010 [2](#ccd26372-bib-0002){ref-type="ref"}. Finally, many emergency percutaneous intervention patients with indications other than ST‐elevation such as refractory unstable angina, NSTEMI, and cardiac arrest are not included within systems to improve door‐to‐balloon time. In contrast to improvements in the Medicare public reporting database, patients with reported nonsystem delays as well as in‐hospital and transfer STEMI fail to achieve a median door‐to‐balloon time ≤90 min and have a substantially higher mortality [4](#ccd26372-bib-0004){ref-type="ref"}, [5](#ccd26372-bib-0005){ref-type="ref"}, [6](#ccd26372-bib-0006){ref-type="ref"}, [7](#ccd26372-bib-0007){ref-type="ref"}. A comprehensive hospital‐wide system to ensure timely reperfusion within 90 min in all emergency PCI patients is needed and may be a novel strategy to reduce myocardial infarction mortality. Therefore, we present the impact on door‐to‐balloon time and mortality of a strategy of emergency department physician or cardiologist one‐call activation of the catheterization lab combined with immediate physical transfer of the patient to an immediately available catheterization lab by in‐house nursing staff prospectively applied across the entire spectrum of emergency PCI.

![The entire spectrum of emergency percutaneous intervention. Emergency status defined as a patient of sufficient acuity that PCI is to be performed immediately (cancelling elective case) in next available room during regular hours or activation of on‐call cath lab team during off‐hours. \[Color figure can be viewed at [wileyonlinelibrary.com](http://wileyonlinelibrary.com).\]](CCD-88-678-g001){#ccd26372-fig-0001}

METHODS {#ccd26372-sec-0006}
=======

Study Design and Protocol Description {#ccd26372-sec-0007}
-------------------------------------

This prospective study was conducted between October 1, 2004 and December 1, 2008 at St. Francis Hospital and Health Center (Beech Grove and Indianapolis, IN), a 591‐bed tertiary care community hospital consisting of two campuses 7 miles apart. Details of the hospital system, the protocol during the historical control period (October 1, 2004--August 31, 2005) and characteristics of the enrolled patients during the historical control period have been previously reported [8](#ccd26372-bib-0008){ref-type="ref"}. Beginning September 1, 2005, we prospectively enrolled a consecutive series of patients with emergency catheterization lab activation irrespective of clinical indication, manner or timing of presentation, activating physician, or location within the hospital. We mandated the ED physicians to activate the catheterization lab for STEMI in the emergency department; cardiologists could activate the catheterization lab for any patient requiring emergent catheterization independent of indication (i.e., STEMI, refractory unstable angina, NSTEMI, cardiogenic shock, or cardiac arrest) or location (i.e., emergency department, inpatient floor, or intensive care unit; Fig. [2](#ccd26372-fig-0002){ref-type="fig"}). The emergency department physician or cardiologist contacted the hospital operator to activate the catheterization lab. The operator subsequently paged the cardiology physician assistant, catheterization lab coordinator, and a critical care unit nurse during regular hours or the on‐call cardiologist, interventional cardiologist, critical care unit nurse, chest pain unit nurse, and the on‐call catheterization team during off‐hours. Four catheterization staff members take home call during off‐hours and are expected to arrive to the hospital within 30 min of laboratory activation.

![Protocol design for standardized treatment of all emergency percutaneous intervention patients. Emergency department physicians or cardiologists identified all patients needing emergency cardiac catheterization/PCI with subsequent immediate transfer protocol by in‐house nursing staff to catheterization lab. PCI = Percutaneous Coronary Intervention.](CCD-88-678-g002){#ccd26372-fig-0002}

Following catheterization lab activation, the in‐house Emergency Heart Attack Response Team (EHART™), consisting of an emergency department nurse, a critical care unit nurse, and a chest pain unit nurse initiated a policy of immediate transfer of the patient to an immediately available catheterization lab. The critical care unit nurse proceeded to the patient\'s location and initiated a standard resuscitation order set with the emergency department or bedside nurse (if patient was not in the emergency department). The nurses then proceeded to immediately transfer the patient to the catheterization lab. The only exceptions to immediate transfer by the nursing staff included hemodynamic compromise (requiring vasopressors, temporary pacing, or balloon pump) and ongoing CPR; these patients were prepared for immediate transfer but transferred by the nursing staff with the cardiologist. The critical care unit nurse could administer dopamine or norepinephrine intravenous drips, perform defibrillation, and direct intubation by respiratory therapy all without prior physician approval in case of sustained hypotension or arrest. The Critical Care Unit modified the work requirements for the EHART™ nurse by assigning the nurse one patient instead of two patients.

To make the cath lab immediately available during regular hours, the catheterization lab coordinator identified a room and staff for the patient. The lab coordinator could remove an elective patient from the lab if the case had not started (defined as cardiologist fully scrubbed at bedside obtaining access). If all rooms were occupied with cases in progress, then the STEMI patient went to the first available room. Upon patient placement on the catheterization lab table, the Emergency Heart Attack Response Team members transferred the patient\'s nursing care to the catheterization team.

To make the cath lab immediately available during off‐hours, the chest pain unit nurse proceeded to the catheterization lab, activated the catheterization lab imaging equipment, and confirmed that the temporary pacemaker, balloon pump, defibrillator, and activated clotting time machine were in working order. This individual subsequently assisted the critical care unit nurse and emergency department nurse in the initial setup of the patient including placement on the catheterization table, monitoring equipment setup, prepping of groins, and assistance with the sterile catheterization lab table. The emergency department nurse and critical care nurse monitored the patient until the third and fourth catheterization staff members arrived and subsequently transferred nursing care to the catheterization team. If the patient was unstable, all staff attended to the patient until safe transfer of care was possible.

For cath lab activations by emergency department (ED) physicians, all activities in the emergency department, during the transfer to the catheterization lab, and during initial setup in the catheterization lab did not require cardiologist presence or input. The cardiologist evaluated the patient and confirmed the appropriateness for emergency catheterization in the emergency department, en route to the catheterization lab, or in the catheterization lab.

Study Endpoints and Statistical Analysis {#ccd26372-sec-0008}
----------------------------------------

Median door‐to‐balloon time was the primary endpoint and was defined as follows: [1](#ccd26372-bib-0001){ref-type="ref"} door‐to‐balloon time for primary emergency department patients, [2](#ccd26372-bib-0002){ref-type="ref"} first door‐to‐balloon time for transfer patients, [3](#ccd26372-bib-0003){ref-type="ref"} activating ECG‐to‐balloon time for patients without ST‐elevation on first ECG and in‐hospital, and [4](#ccd26372-bib-0004){ref-type="ref"} activation‐to‐balloon time for patients with activating indication other than STEMI. Secondary endpoints included the proportion of door‐to‐balloon times ≤90 min, infarct size measured by peak creatinine kinase within the first 24 hr [9](#ccd26372-bib-0009){ref-type="ref"}, [10](#ccd26372-bib-0010){ref-type="ref"}, [11](#ccd26372-bib-0011){ref-type="ref"}, hospital costs (total, direct, and indirect), and hospital length of stay. Hospital cost data reflect the actual costs involved in the delivery of care to each patient and were determined by the hospital\'s cost‐accounting software (Alliance for Decision Support, Avega Health Systems. El Segundo, CA). Mortality was determined by hospital medical record review and via query of Social Security Death Index. Using a national mortality database, we analyzed 30‐day all‐cause unadjusted mortality and 30‐day all‐cause risk‐standardized mortality ratios for patients diagnosed with acute myocardial infarction for our hospital compared to national averages for the time periods of July 2008 and June 2008 and July 2006 to June 2009. All patients provided informed consent, and our institutional review board approved the study.

Time values are presented as medians with interquartile ranges and were analyzed using one sample Wilcoxon signed rank test against a median value of 90 min. The proportion of patients with door‐to‐balloon ≤90 min was compared to the goal of 75% by the binomial test. Continuous data are presented as means ± standard deviation and were analyzed by two sample *t*‐tests. Categorical data are presented as proportions and were analyzed by Fisher\'s exact test. *P* \< 0.05 was considered statistically significant. Stata Software (version 8.2, College Station, TX) and Prism (version 6.0d, La Jolla, CA) were used for statistical analyses.

RESULTS {#ccd26372-sec-0009}
=======

STEMI accounted for 83.1% of 673 consecutive emergency catheterization lab activations (Fig. [3](#ccd26372-fig-0003){ref-type="fig"}). The proportion undergoing diagnostic catheterization was slightly higher in the STEMI activation group compared to indications other than STEMI (98.6% vs. 94.7%, *P* = 0.0194) while the proportion undergoing PCI was markedly higher in the STEMI group (83.4% vs. 52.6%, *P* \< 0.0001).

![Summary of 679 consecutive emergency catheterization lab activations according to indication and origin of patient. ECG = Electrocardiogram, STEMI = ST‐Elevation Myocardial Infarction.](CCD-88-678-g003){#ccd26372-fig-0003}

STEMI patients had lower rates of prior CABG and peripheral vascular disease compared to patients with indications other than STEMI (Table [1](#ccd26372-tbl-0001){ref-type="table-wrap"}). Patient with indications other than STEMI were more likely to have off‐hours cath lab activations, self‐transportation, and left circumflex involvement as the infarct‐related artery. Emergency department physicians accounted for 81.1% of cath lab activations for STEMI but only 11.7% of activations for indications other than STEMI.

###### 

Demographics, Initial Presentation Characteristics, and Treatment Outcomes in STEMI and Emergent Activation Patients Undergoing PCI

                                                   STEMI activation + PCI (*N* = 466)                     Emergent indication activation + PCI (*N* = 60)      *P* value
  ------------------------------------------------ ------------------------------------------------------ ---------------------------------------------------- -----------
  Age, y                                           60 ± 13                                                59 ± 13                                              0.449
  Female gender                                    148 (31.8)                                             13 (21.7)                                            0.136
  Health insurance                                                                                                                                             
  Private                                          241 (51.7)                                             35 (58.3)                                            0.7368
  Medicare                                         160 (34.3)                                             19 (31.7)                                            **...**
  Medicaid                                         15 (3.2)                                               1 (1.7)                                              **...**
  Self‐pay                                         50 (10.7)                                              5 (8.3)                                              **...**
  Medical history                                                                                                                                              
  Current smoker                                   228 (48.9)                                             23 (38.3)                                            0.132
  Diabetes                                         85 (18.2)                                              11 (18.3)                                            1
  Hypertension                                     273 (58.6)                                             32 (53.3)                                            0.488
  Hypercholesterolemia                             240 (51.5)                                             34 (56.7)                                            0.494
  Family history of CHD                            156 (33.5)                                             28 (46.7)                                            0.061
  Congestive heart failure                         21 (4.5)                                               5 (8.3)                                              0.203
  COPD                                             45 (9.7)                                               3 (5)                                                0.340
  Prior carotid disease                            7 (1.5)                                                2 (3.3)                                              0.274
  Prior PCI                                        113 (24.2)                                             18 (30)                                              0.343
  Prior CABG                                       24 (5.2)                                               9 (15)                                               0.0076
  PVD                                              29 (6.2)                                               10 (16.7)                                            0.0078
  Stroke                                           15 (3.2)                                               1 (1.7)                                              1
  Initial presentation                                                                                                                                         
  Regular hours                                    159 (34.1)                                             8 (13.3)                                             0.0010
  Transferred to PCI                               79 (17)                                                5 (8.3)                                              0.094
  Symptom onset to arrival                                                                                                                                     
  ≤1 h                                             183 (46.2)                                             16 (38.1)                                            0.0240
  \>1--2 h                                         96 (24.2)                                              5 (11.9)                                             **...**
  \>2--6 h                                         74 (18.7)                                              11 (26.2)                                            **...**
  \>6--12 h                                        25 (6.3)                                               4 (9.5)                                              **...**
  \>12 h                                           18 (4.5)                                               6 (14.3)                                             **...**
  Unknown                                          70 (15)                                                18 (30)                                              0.0056
  Chest pain at presentation                       423 (90.8)                                             56 (93.3)                                            0.636
  Prehospital ECG                                  120 (25.8)                                             9 (15)                                               0.079
  Ambulance arrival                                207 (44.4)                                             13 (21.7)                                            0.0007
  Field defibrillation                             17 (3.6)                                               0 (0)                                                0.240
  Field CPR                                        13 (2.8)                                               0 (0)                                                0.379
  Field intubation                                 7 (1.5)                                                0 (0)                                                1
  Heart rate, bpm                                  78 ± 21[a](#ccd26372-note-0005){ref-type="fn"}         81 ± 20                                              0.294
  Systolic blood pressure, mm Hg                   139 ± 41                                               139 ± 33                                             0.987
  Diastolic blood pressure, mm Hg                  81 ± 22                                                82 ± 19                                              0.761
  Location of infarct                                                                                                                                          
  Anterior                                         153 (32.8)                                             N/A                                                  **...**
  Inferior                                         278 (59.7)                                             N/A                                                  **...**
  Lateral (isolated)                               31 (6.7)                                               N/A                                                  **...**
  LBBB                                             4 (0.9)                                                N/A                                                  **...**
  ECG leads with ST‐elevation                                                                                                                                  
  2                                                84 (18.1)                                              N/A                                                  **...**
  3--4                                             241 (52.1)                                             N/A                                                  **...**
  ≥5                                               138 (29.8)                                             N/A                                                  **...**
  Elevated cardiac troponin                        459 (98.5)                                             53 (88.3)                                            \<0.0001
  Cardiogenic shock                                83 (17.8)                                              8 (13.3)                                             0.471
  Cath lab activation                                                                                                                                          
  ED physician                                     378 (81.1)                                             7 (11.7)                                             \<0.0001
  Cardiologist                                     88 (18.9)                                              53 (88.3)                                            **...**
  Medical therapy                                                                                                                                              
  Aspirin                                          449 (96.6)[a](#ccd26372-note-0005){ref-type="fn"}      59 (98.3)                                            1
  Beta blocker                                     382 (82.2)[a](#ccd26372-note-0005){ref-type="fn"}      53 (88.3)                                            0.4597
  Heparin                                          447 (95.9)                                             56 (93.3)                                            0.092
  Glycoprotein llb/llla inhibitor                  442 (94.8)                                             54 (91.5)[b](#ccd26372-note-0006){ref-type="fn"}     0.357
  Bivalirudin                                      4 (0.9)                                                1 (1.7)                                              0.456
  Thrombolytics                                    14 (3)                                                 0 (0)                                                0.386
  In‐hospital cardiopulmonary arrest               46 (9.9)                                               3 (5)                                                0.342
  In‐hospital defibrillation before PCI            27 (5.8)                                               0 (0)                                                0.060
  In‐hospital CPR prior to PCI                     17 (3.6)                                               1 (1.7)                                              0.708
  In‐hospital intubation prior to PCI              29 (6.2)                                               2 (3.3)                                              0.561
  Temporary pacemaker before PCI                   29 (6.2)                                               0 (0)                                                0.063
  IABP before PCI                                  5 (1.1)                                                0 (0)                                                1
  IABP after PCI                                   46 (9.9)                                               6 (10)                                               1
  Catheterization results                                                                                                                                      
  Infarct‐related artery                                                                                                                                       
  Left main                                        2 (0.4)                                                2 (3.3)                                              0.0056
  Left anterior descending                         170 (36.5)                                             17 (28.3)                                            **...**
  Left circumflex                                  59 (12.7)                                              16 (26.7)                                            **...**
  Right coronary                                   225 (48.3)                                             23 (38.3)                                            **...**
  Bypass graft                                     10 (2.1)                                               2 (3.3)                                              **...**
  Treatment                                                                                                                                                    
  Balloon angioplasty only                         61 (13.1)                                              15 (25)                                              0.1085
  Balloon angioplasty/stent                        401 (86.1)                                             45 (75)                                              **...**
  Balloon angioplasty/angiojet                     3 (0.6)                                                0 (0)                                                **...**
  Balloon angioplasty/rotoblation/stent            1 (0.2)                                                0 (0)                                                **...**
  Type of stent                                                                                                                                                
  Bare metal stent                                 218 (54.2)                                             21 (46.7)                                            0.080
  Drug‐eluting stent                               181 (45)                                               22 (48.9)                                            **...**
  Bare metal stent and drug‐eluting stent          3 (0.7)                                                2 (4.4)                                              **...**
  Interventional cardiologist experience, years    11 ± 10                                                11 ± 10                                              0.828
  Mean infarct size, peak creatinine kinase IU/L   1,683 ± 2,494[c](#ccd26372-note-0007){ref-type="fn"}   975 ± 1,656[d](#ccd26372-note-0008){ref-type="fn"}   0.0378
  Mean DRG relative weight                         2.6806 ± 1.605                                         2.8054 ± 2.6235                                      0.603
  Mean total hospital costs, \$                    20,408 ± 16,830                                        20,197 ± 13,833                                      0.926
  Mean direct hospital costs, \$                   13,853 ± 11,960                                        13,624 ± 9,879                                       0.887
  Mean indirect hospital costs, \$                 6,554 ± 4,993                                          6,574 ± 4,066                                        0.977
  Mean hospital length of stay, day                4 ± 4                                                  5 ± 4                                                0.412
  Mean time in coronary care unit, h               58 ± 74                                                58 ± 72                                              0.976
  All cause in‐hospital mortality                  23 (4.9)                                               2 (3.3)                                              0.756
  All cause 30 day mortality                       27 (5.8)                                               2 (3.3)                                              0.761
  All cause 180 day mortality                      31 (6.7)                                               3 (5)                                                0.785
  All cause 1 year mortality                       36 (7.7)                                               3 (5)                                                0.604

Values are expressed as mean ± SD or *n* (%). ED, emergency department; CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; PCI, percutaneous intervention; CABG, coronary artery bypass grafting; PVD, peripheral vascular disease; ECG, electrocardiogram; CPR, cardiopulmonary resuscitation; LBBB, left bundle branch block; cath lab, catheterization laboratory; IABP, intra‐aortic balloon pump; and DRG, diagnosis‐related group.

*n* = 465.

*n* = 59.

*n* = 446.

*n* = 57.

Compared to historical controls, the clinical profile of STEMI patients undergoing PCI originating from the primary emergency department and in transfer (Groups A1 and A3 from Fig. [3](#ccd26372-fig-0003){ref-type="fig"}) was similar (Supporting Information, Appendix). The proportion treated within 90 min increased from 28.3% to 85.3% (*P* \< 0.0001; Table [2](#ccd26372-tbl-0002){ref-type="table-wrap"}). There was a 10‐fold increase in the treatment within 45 min and a nearly 10‐fold reduction in treatment requiring \>120 min (*P* \< 0.0001). Mean infarct size, hospital length of stay, total and direct hospital costs all decreased. PCI unadjusted all‐cause in‐hospital, 30‐day, and 1 year mortality were unchanged.

###### 

Door‐to‐Balloon Time, Infarct Size, Hospital Length of Stay, Costs, and All‐Cause Mortality Before and After Process Change in Primary and Transfer ED Patients

                                                    Cardiology only activation/routine transfer October 1, 2004--August 31, 2005(*N* = 60)   ED physician + cardiologist activation/immediate transfer September 1, 2005--December 31, 2008(*N* = 382)   *P* value
  ------------------------------------------------- ---------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------- -----------
  Door‐to‐balloon (min)                                                                                                                                                                                                                                  
  ≤45                                               1 (1.7)                                                                                  65 (17)                                                                                                     \<0.0001
  46--60                                            5 (8.3)                                                                                  77 (20.2)                                                                                                   
  61--90                                            11 (18.3)                                                                                184 (48.2)                                                                                                  
  91--120                                           15 (25)                                                                                  38 (9.9)                                                                                                    
  \>120                                             28 (46.7)                                                                                18 (4.7)                                                                                                    
  Mean infarct size, peak creatinine kinase, IU/L   2,623 ± 3,329                                                                            1,677 ± 2,585                                                                                               0.0123
  Mean hospital length of stay, days                6 ± 7                                                                                    4 ± 3                                                                                                       0.0153
  Mean DRG relative weight                          3.67 ± 2.52                                                                              2.67 ± 1.57                                                                                                 \<0.0001
  Mean total hospital costs, \$                     26,826 ± 29,497                                                                          19,712 ± 15,338                                                                                             0.0043
  Mean direct hospital costs, \$                    19,585 ± 21,946                                                                          13,395 ± 11,002                                                                                             0.0006
  Mean indirect hospital costs, \$                  7,240 ± 7,571                                                                            6,317 ± 4,471                                                                                               0.184
  All‐cause in‐hospital mortality                   3 (5.0)                                                                                  16 (4.2)                                                                                                    0.732
  All‐cause 30‐day mortality                        3 (5.0)                                                                                  20 (5.2)                                                                                                    1
  All‐cause 180 day mortality                       4 (6.7)                                                                                  24 (6.3)                                                                                                    0.782
  All‐cause 1 year mortality                        4 (6.7)                                                                                  29 (7.6)                                                                                                    1

For all patient types, median door‐to‐balloon time was 68 min with 85.7% of patients treated within 90 min (Table [3](#ccd26372-tbl-0003){ref-type="table-wrap"}). For STEMI patients presenting to the primary emergency department (Fig. [3](#ccd26372-fig-0003){ref-type="fig"}, Group A1), a median door‐to‐balloon time less than 90 min was achieved overall and in every subgroup. Similarly, the goal of 75% of patients to be treated within 90 min was achieved except in patients with prior CABG and patients presenting without chest pain. Furthermore, all emergency PCI patient subgroups achieved a median door‐to‐balloon time ≤90 minute; nearly all achieved the goal of 75% of patients within 90 min except for STEMI transfer patients and those with STEMI in‐hospital.

###### 

Median Door‐to‐Balloon and Proportion of Door‐to‐Balloon Times Within 90 min

  Group (Fig. [2](#ccd26372-fig-0002){ref-type="fig"})   Category                                     *N*                  Median Door‐to‐balloon   Median≤90 min *P* value   %(*N*) ≤90 min   75% door‐to‐balloon ≤ 90 min *P* value
  ------------------------------------------------------ -------------------------------------------- -------------------- ------------------------ ------------------------- ---------------- ----------------------------------------
  A+B                                                    STEMI and emergent overall                   526                  68 (53.75,82)            \<0.0001                  85.7% (451)      \<0.0001
  A                                                      STEMI overall                                466                  68 (53,82)               \<0.0001                  85.2% (397)      \<0.0001
  A1                                                     STEMI primary ED                             312                  62.5 (47.25,76)          \<0.0001                  90.4% (282)      \<0.0001
  A1 Subgroups                                           Regular hours                                113                  48 (43,62)               \<0.0001                  94.7% (107)      \<0.0001
  Off hours                                              199                                          69 (59,79)           \<0.0001                 87.9% (175)               \<0.0001         
  Female                                                 99                                           66 (50,78)           \<0.0001                 88.9% (88)                0.0010           
  Male                                                   213                                          61 (47,75)           \<0.0001                 91.1% (194)               \<0.0001         
  Ambulance arrival                                      174                                          61 (46,74)           \<0.0001                 93.7% (163)               \<0.0001         
  Nonambulance arrival                                   138                                          65.5 (49,80.25)      \<0.0001                 86.2% (119)               0.0016           
  \<65 years                                             201                                          61 (47,74.5)         \<0.0001                 93% (187)                 \<0.0001         
  ≥65 years                                              111                                          66 (48,81)           \<0.0001                 85.6% (95)                0.0084           
  Prior CABG                                             16                                           83 (69,108.3)        0.4874                   68.8% (11)                0.5669           
  No prior CABG                                          296                                          61 (47,74.75)        \<0.0001                 91.6% (271)               \<0.0001         
  Chest pain on presentation                             286                                          62 (47,75)           \<0.0001                 92.3% (264)               \<0.0001         
  No chest pain on presentation                          26                                           72.5 (48.75,94)      0.0456                   69.2% (18)                0.4992           
  Symptom onset to presentation known                    275                                          62 (48,75)           \<0.0001                 92.4% (254)               \<0.0001         
  Symptoms onset to presentation unknown                 37                                           71 (43.5,91)         0.0035                   75.7% (28)                \>0.9999         
  Field cardiopulmonary arrest                           13                                           50 (41,73)           0.0024                   92.3% (12)                0.2069           
  No field cardiopulmonary arrest                        299                                          63 (48,76)           \<0.0001                 90.3% (270)               \<0.0001         
  In‐hospital cardiopulmonary arrest prior to PCI        27                                           71 (45,77)           0.0020                   81.5% (22)                0.5130           
  No in‐hospital cardiopulmonary arrest prior to PCI     285                                          62 (47.5,76)         \<0.0001                 91.2% (260)               \<0.0001         
  Temporary pacemaker/IABP prior to PCI                  20                                           67 (45.75,74.25)     0.0002                   95% (19)                  0.0382           
  No temporary pacemaker/IABP prior to PCI               292                                          62 (47.25,76)        \<0.0001                 90.1% (263)               \<0.0001         
  Cardiogenic shock                                      49                                           68 (49.5,75.5)       \<0.0001                 87.8% (43)                0.0461           
  No cardiogenic shock                                   263                                          62 (47,76)           \<0.0001                 90.9% (239)               \<0.0001         
  Interventionalist experience \<3 years                 68                                           70.5 (55.75,87.75)   \<0.0001                 80.9% (55)                0.3267           
  Interventionalist experience 3‐10 years                127                                          57 (45,72)           \<0.0001                 93.7% (119)               \<0.0001         
  Interventionalist experience \>10 years                117                                          64 (47.5,75)         \<0.0001                 92.3% (108)               \<0.0001         
  A2                                                     STEMI primary ED 1^st^ ECG No ST elevation   32                   66.5 (54.25,77)          \<0.0001                  96.9% (31)       0.0012
  A3                                                     STEMI transfer ED                            70                   84 (74,98.25)            0.1659                    62.9% (44)       0.9917
  A4                                                     STEMI transfer ED 1^st^ ECG No ST Elev       9                    75 (62,83.5)             0.0117                    88.9% (8)        0.3003
  A5                                                     STEMI in‐hospital                            43                   70 (63,92)               \<0.0001                  74.4% (32)       0.6145
  B                                                      Emergent overall                             60                   68 (57,81.5)             \<0.0001                  90% (54)         0.0031
  B1                                                     Emergent primary ED                          30                   67.5 (56.5,80.5)         0.0021                    86.7% (26)       0.0979
  B2                                                     Emergent transfer ED                         5                    79 (69.5,94)             0.4375                    80% (4)          0.6328
  B3                                                     Emergent in‐hospital                         25                   66 (55,81)               \<0.0001                  96% (24)         0.0070

Door‐to‐balloon defined (1) conventionally for primary ED patients, (2) first door‐to‐balloon for transfer patients, (3) activating ECG‐to‐balloon for 1st ECG without ST elevation, and (4) activation to balloon for emergency activations for indications other than STEMI.

Compared to national averages, there were substantially lower unadjusted 30‐day all‐cause mortality for acute myocardial infarction and 30‐day all‐cause risk‐standardized mortality ratios for the time periods of July 2008 and June 2008 and July 2006 to June 2009 (Fig. [4](#ccd26372-fig-0004){ref-type="fig"}).

![All‐cause 30‐day mortality rate during the time period of this study compared to national averages. The protocol led to a substantial reduction in unadjusted mortality and risk‐standardized mortality ratios for all‐cause 30‐day mortality compared to national averages in both 2005--2008 and 2006--2009.](CCD-88-678-g004){#ccd26372-fig-0004}

DISCUSSION {#ccd26372-sec-0010}
==========

Our study is the first description of a hospital‐wide systems approach to achieve rapid door‐to‐balloon time by implementing a uniform strategy across the entire spectrum of emergency PCI. This consistent performance in door‐to‐balloon time was evident in patients at high risk for delayed door‐to‐balloon time, transfer patients, and patients requiring emergency PCI for indications other than STEMI (Fig. [5](#ccd26372-fig-0005){ref-type="fig"}). Important secondary benefits included a 35% reduction in myocardial infarct size, a decrease in hospital length of stay by 2 days, and a more than \$7,000 reduction in total costs for the hospital admission. Most importantly, although PCI‐related mortality did not change, both unadjusted and risk‐adjusted mortality for all acute myocardial infarction patients at 30 days were dramatically lower than national averages.

![Achieving rapid door‐to‐balloon time across the entire spectrum of emergency percutaneous intervention. ECG = Electrocardiogram, IABP = Intra‐Aortic Balloon Pump, NSTEMI = Non‐ST‐elevation myocardial infarction, PCI = Percutaneous Coronary Intervention, STEMI = ST‐elevation myocardial infarction, USA = Unstable Angina. \[Color figure can be viewed at [wileyonlinelibrary.com](http://wileyonlinelibrary.com).\]](CCD-88-678-g005){#ccd26372-fig-0005}

Delays in door‐to‐balloon time can be ascribed to either system‐centered delays or patient‐related reasons [12](#ccd26372-bib-0012){ref-type="ref"}. System‐centered delays, such as delay in cath lab staff arrival, are believed to be amenable to process improvement. Patient‐related reasons, such as cardiac arrest or the need for additional procedures, are believed to be appropriate justifications for delayed door‐to‐balloon times. However, our data indicate that virtually every patient subgroup including cardiorespiratory arrest, cardiogenic shock, and the need for additional procedures, can have PCI performed within a median door‐to‐balloon ≤90 min and even the more stringent criteria of 75% within 90 min. These findings refute the belief that delays in door‐to‐balloon time are inevitable in high‐risk patients for patient‐related reasons.

The applicability of our protocol extends beyond the focused population of patients who present to emergency departments with STEMI and underscores the heterogeneity of clinical presentations of patients needing emergency PCI (Fig. [1](#ccd26372-fig-0001){ref-type="fig"}). Nearly 10% of all STEMI presentations have an initial ECG without ST‐elevation [13](#ccd26372-bib-0013){ref-type="ref"}. The in‐hospital development of STEMI is also an important source of patients needing emergency PCI with a very high mortality rate [6](#ccd26372-bib-0006){ref-type="ref"}, [12](#ccd26372-bib-0012){ref-type="ref"}, [14](#ccd26372-bib-0014){ref-type="ref"}. In fact, our study is the first study to demonstrate the ability to provide reperfusion to in‐hospital STEMI within 90 min from detection. We also included patients who require emergency catheterization for reasons other than STEMI including unstable angina/non‐ST‐elevation myocardial infarction complicated by refractory angina, hemodynamic or electrical instability, cardiac arrest, and cardiogenic shock. Attention to all of these patients extends the focus of timely reperfusion from the emergency department STEMI populations to the broader population of all patients who require emergency catheterization and revascularization.

A Michigan study revealed that the decrease in door‐to‐balloon time led to no improvement in PCI in‐hospital mortality [15](#ccd26372-bib-0015){ref-type="ref"}. Furthermore, at a national level, improvements in door‐to‐balloon time also led to no temporal improvement in PCI in‐hospital or 30‐day mortality [16](#ccd26372-bib-0016){ref-type="ref"}. Current public reporting criteria and national clinical registries allow for exclusion of patients for CPR, defibrillation, and intubation within 90 min of arrival or those with clinical reasons documented within the medical record (i.e., difficulty with access, the need for additional workup or procedures prior to PCI, or time required for patient). These allowances have led to "erosion of the denominator" of the public reporting door‐to‐balloon metric as the number of patients excluded for nonsystem delays has increased from 3.7% to 8.1% between the years 2005 and 2010 [2](#ccd26372-bib-0002){ref-type="ref"}. The potentially excluded populations account for only 18.1% of patients but 54% of deaths [4](#ccd26372-bib-0004){ref-type="ref"}. Similarly, in the United States CathPCI registry, in‐hospital mortality for patients without reported nonsystem delays was 2.5% compared with 15.1% for those with a reported nonsystem delay [5](#ccd26372-bib-0005){ref-type="ref"}. As the benefits of improved door‐to‐balloon time are concentrated in high‐risk subgroups [17](#ccd26372-bib-0017){ref-type="ref"}, public reporting and clinical registries should require reporting of door‐to‐balloon times for all patients undergoing emergency PCI.

Hospitals typically require STEMI patients to wait in the emergency department until a certain number of catheterization staff have arrived and for the catheterization lab to be ready prior to transfer [18](#ccd26372-bib-0018){ref-type="ref"}. Time spent within the emergency department and transferring to the catheterization lab is the largest component of door‐to‐balloon time. Immediate transfer to an immediately available cath lab by an in‐house nursing staff is one of the most effective steps to reduce door‐to‐balloon time. This process has now been validated by our experience, in academic medical settings, and outside the United States [8](#ccd26372-bib-0008){ref-type="ref"}, [19](#ccd26372-bib-0019){ref-type="ref"}, [20](#ccd26372-bib-0020){ref-type="ref"}. Widespread adoption clinically and within the guidelines should be strongly encouraged.

There has been considerable focus on prehospital identification of STEMI. However, only 36% of emergency PCI patients in our study were eligible for prehospital identification and treatment. Of note, self‐transportation is a common mode of presentation by STEMI patients occurring approximately 50%--70% of the time---a figure which is consistently seen worldwide [21](#ccd26372-bib-0021){ref-type="ref"}. Thus, systems of care like ours that ensure equally rapid treatment for patients presenting via ambulance or self‐transportation should be instituted.

LIMITATIONS {#ccd26372-sec-0011}
===========

Although the historical and process improvement cohorts were clinically similar, baseline differences cannot be completely accounted for because of our study\'s nonrandomized nature. Our before and after outcome and cost comparisons (Table [2](#ccd26372-tbl-0002){ref-type="table-wrap"}) are limited to primary and transfer ED STEMI patients; data from the other emergency PCI patient populations in this study (i.e., initial ECG without ST‐elevation, in‐hospital, and activation indications other than STEMI) were not collected during the historical time period. However, these primary and ED transfer patients did account for more than 70% of the patients treated with PCI. Our study describes a cohort of patients from 2004 to 2008; however, we believe that the system design remains relevant today particularly given ongoing challenges with rapid treatment of in‐hospital and transfer STEMI. Our study reflects a single center United States experience and may not be applicable outside the United States. Our acute myocardial infarction mortality data reflect only our Medicare population. We could not analyze mortality data prior to July 2005 as it is not available from the Centers of Medicare and Medicaid Services. The start date of the public reporting mortality data (July 2005) do not identically match the start date for our process improvement (September 2005) as the two projects were performed independently. Our mortality findings were statistically and clinically significant, but the study was not primarily designed to measure mortality.

CONCLUSION {#ccd26372-sec-0012}
==========

Optimal door‐to‐balloon times can be achieved across a hospital system by broad implementation of ED physician or cardiology one‐call activation of the catheterization lab and immediate transfer protocol by an in‐house nursing staff. The strategy can be further extended to patients who do not have ST‐elevation on initial ECG, to in‐hospital STEMI, and to patients who undergo emergency catheterization for clinical indications other than STEMI. Ultimately, this system can align improvements in door‐to‐balloon time with reduced myocardial infarction mortality rates. Widespread adoption of this comprehensive strategy can substantially improve the care of a broad population of patients undergoing emergency PCI worldwide.
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